Biohaven’s Stock Rises After Director’s Purchase
- United States Steel Corp. (X) experienced a 9.5% increase in share price following Nippon Steel’s proposal to the U.S. government for an acquisition of the company.
- Shares of Biohaven Ltd. (BHVN) rose by 4.4% after director John Childs revealed he bought 29,000 shares.
- Conversely, Sangamo Therapeutics Inc. (SGMO) saw a dramatic drop of 56.4% after Pfizer Inc. (PFE) ended their agreement to co-develop gene therapy for hemophilia A.
- Builders FirstSource Inc. (BLDR) faced a slight decline of 0.3%, impacted by a forecasted weak supply trend in the housing market for 2025.
Discover Zacks’ Top Picks for 2024
Don’t miss your chance to explore Zacks’ 10 top stock selections for 2025. Curated by Zacks Research Director Sheraz Mian, this portfolio has achieved remarkable results. Since its launch in 2012 until November 2024, the Zacks Top 10 Stocks portfolio recorded a gain of 2,112.6%, significantly outperforming the S&P 500’s +475.6%. Mian meticulously analyzed 4,400 companies covered by the Zacks Rank to identify the top 10 to buy and hold for 2025. Be among the first to check out these newly released stocks with great potential.
Want the latest recommendations from Zacks Investment Research? Today you can download “5 Stocks Set to Double.” Click to access this free report.
Pfizer Inc. (PFE): Free Stock Analysis Report
United States Steel Corporation (X): Free Stock Analysis Report
Builders FirstSource, Inc. (BLDR): Free Stock Analysis Report
Sangamo Therapeutics, Inc. (SGMO): Free Stock Analysis Report
Biohaven Ltd. (BHVN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
